CN2870896Y - Target blood-vessel radiant positioner of laser therapeutic instrument - Google Patents
Target blood-vessel radiant positioner of laser therapeutic instrument Download PDFInfo
- Publication number
- CN2870896Y CN2870896Y CN 200520145013 CN200520145013U CN2870896Y CN 2870896 Y CN2870896 Y CN 2870896Y CN 200520145013 CN200520145013 CN 200520145013 CN 200520145013 U CN200520145013 U CN 200520145013U CN 2870896 Y CN2870896 Y CN 2870896Y
- Authority
- CN
- China
- Prior art keywords
- laser
- blood
- connecting rod
- positioner
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A target blood-vessel radiant positioner of laser therapeutic instrument is characterized in that it comprising locating mastoid and connecting rod. The locating mastoid is connected with the outer end of connecting rod, while the back of casing of therapeutic apparatus is connected with the other end of connecting rod about 2cm above the laser on the top of back of casing, the connecting line with the nearest laser is parallel to one side of the casing. The locating parameters of targeting blood vessel locator are designed according to the artery strike of human body and the credibility interval of radial artery included angle alpha in domestic radial artery measurement reports. The device's locating point and the laser form a certain angle according to the strike of radial artery. When the locating point is aligned with the radius styloid process, the laser projection facula will completely cover the radial artery, to accurately irradiate the targeting blood vessel for avoiding laser blind irradiation and improving the effective laser exposure rate. The utility model can greatly improve the curative effect to be used in treatment of cardio-cerebrovascular disease, hypervicosity of blood, hyperlipidemia, hypertension and hyperglycemia,etc.
Description
Technical field
This utility model relates to a kind of target vessel irradiation positioner of medical laser treatment instrument, is mainly used in when using laser therapeutic apparatus to carry out the blood vessel irradiation treatment, and laser instrument is accurately positioned on the target vessel that needs irradiation treatment.The clinical laser therapy field that is used for the treatment of person in middle and old age's disease that cardiovascular and cerebrovascular disease and peripheral vascular disease and hyperlipidemia, high blood viscosity, hypertension, hyperglycemia, metabolic syndrome etc. cause.
Background technology
According to World Health Organization's statistics, cardiovascular and cerebrovascular disease is the principal disease that threatens human health, its mortality rate seniority among brothers and sisters umber one.At present China is because of death toll due to the cardiovascular and cerebrovascular disease disease has 2,600,000 every year approximately, account for total dead constitute 45%, on average per hour dead about 300 people, the burden of causing for society and family is very heavy.World Health Organization (WHO) has classified cardiovascular and cerebrovascular disease as one of current full scope of organization overall work emphasis, and control cardiovascular and cerebrovascular disease is problem and the task that the medical personnel faces jointly comprehensively.The research of cardiovascular and cerebrovascular disease needs multidisciplinary intersection, and Laser Biomedicine cooperates with life sciences and other basic subject, and basic with clinical combines.Face the severe situation of present cardiovascular disease prevention, the prevention of China's urgent need raising cardiovascular and cerebrovascular disease and treatment level are to promote people ' s health.
Along with the develop rapidly of medical laser technology, laser therapy has obtained than quantum jump at the applied research in cardiovascular disease prevention field.Early stage laser therapy cardiovascular and cerebrovascular disease is used the method for intravascular irradiation more, to treat in the optical fiber insertion blood vessel, but because optical fiber inserts wound and the infection risk that brings, can only carry out, its clinical wide popularization and application is restricted in the medical institutions that possess the conditions for sterilization strictness.And laser extravascular irradiation method in recent years is guaranteed the safety of this therapy, has adapted to the needs of cardiovascular and cerebrovascular disease prevention and treatment, demonstrates application prospects.
Laser extravascular irradiation is the energy with the low-energy laser light quantum, the transdermal fascia tissue, muscle and blood vessel wall, absorbed by hemoglobin (hemoglobin is the oxygen carrier albumen in the erythrocyte), make erythrocyte appearance lipoid layer solution-off, the normal charged load of erythrocyte is restored, the deformability of erythrocyte is strengthened, improve hemorheological property, blood viscosity lowering, blood fat reducing, blood sugar lowering, improve permeability of cell membrane, strengthen the ability of blood transport oxygen, thereby improve cardiac muscular tissue, the blood supply oxygen supply of brain and whole body, promote carbohydrate metabolism, blood sugar lowering, promote the activation of plurality of enzymes in the body and extensive biological effect correspondingly, thereby reach the effect of treatment cardiovascular and cerebrovascular disease.
In the laser extravascular irradiation treatment, the laser external exposure accurate positioning of therapeutic instrument is the important factors that concerns curative effect, has only accurately to be positioned target vessel, just may reach the purpose of effective treatment cardiovascular and cerebrovascular disease.The shallow table tremulous pulse of human body is selected at the laser extravascular irradiation position usually---as radial artery popliteal tremulous pulse, carotid artery etc., other position is thinner relatively for skin that covers because of its body surface and tissue, the low-energy laser external exposure is easy to the transdermal tissue and plays therapeutical effect, therefore, when extra-vascular irradiation, determine irradiation position, reducing blind photograph is the basis that guarantees curative effect, and confirm that the blood vessel trend then is to determine the localized prerequisite of irradiation, with the radial artery is example, " practical anatomical atlas upper limb fascicle " (profound scholar Lian chief editor, second edition in 2004, Shanghai science tech publishing house publishes) record: " body surface symbol of radial artery is: by the line of fossa cubitalis mid point below 2.5cm to processus styloideus radii ", the 5th Affiliated Hospital of Henan College Of Traditional Chinese Medicine associating Zhongshan Medical Univ. has extracted and has had south in view of the above, distribute representational compatriots' sample of north crowd has carried out the sampling measurement of radial artery trend, sampling measurement is the result show: the radial artery of human body is not to be a vertical line, it is actually a blood vessel with 5 °～15 ° of angles, and the sampling measurement result of radial artery trend provides scientific basis for the design of radial artery target vessel localizer.
Have problems at present: effective irradiation location of laser extravascular irradiation treatment is to improve effective irradiated area in the unit interval, and assurance laser light quantum directly acts on target vessel, guarantees an outstanding key problem in technology of therapeutic effect.But disclosed multiple laser extravascular irradiation therapeutic equipment all exists no target vessel and accurately locatees design in the prior art, causes effective target vessel irradiation dose deficiency, can not guarantee the problem of curative effect.
Summary of the invention
The purpose of this utility model just provides a kind of target vessel irradiation positioner of laser therapeutic apparatus, and solving can't accurately locating that prior art exists, illuminated blood vessel makes the effective irradiation dose of laser not enough and be difficult to guarantee the problem of curative effect.The target vessel localizer of the specialty of this utility model design can accurately be thrown at target vessel and shine, the key issue that solves is to improve the target vessel irradiated area, improve the effective exposure rate of laser, avoid laser blind, thereby the treatment curative effect of cardio-cerebrovascular diseases is guaranteed according to phenomenon.
The technical solution of the utility model: comprise location mastoid process and connecting rod, the location mastoid process is connected the outer end of connecting rod, the other end of connecting rod is connected with the casing back side of therapeutic instrument, this junction is positioned at about 2cm place, top of the uppermost laser instrument at the casing back side, and is parallel with one side of casing with the line of nearest laser instrument.
Described connecting rod is a screw rod, and screws in the screw of described casing correspondence, is polished rod in the part near the location mastoid process of screw rod, is provided with the graduated scale along length direction on the surface, is provided with anti-skidding stricture of vagina at the side face of mastoid process.
Described connecting rod is by slide bar, and this slide bar vertically slides and inserts in the slide opening of described casing back side correspondence, is provided with in the inner of slide bar and whenever pushes the mechanism of once alternately stretching out with indentation.
At the groove that the outer end of the slide opening of described casing is provided with and described location mastoid process is coincide; On described slide bar, be provided with scale.
The target vessel localizer of the specialty of this utility model design can guarantee accurate alignment targets arteries throwing photograph, the key issue that solves is the target vessel irradiated area, improve the effective exposure rate of laser, avoid laser blind according to phenomenon, thereby it is sticking to reach reduction blood, blood fat reducing, improve the lipolysaccharide metabolism, remove the non-healthy material in the blood, vessel softening, unimpeded blood flow, that improves blood takes oxygen and oxygen delivery capacity, thereby the assurance arterial blood is directly supplied with heart, the competent blood oxygen of each histoorgan of brain and human body, effectively improve arterial oxygen content, increase arterial oxygen saturation, the purpose of treatment cardiovascular and cerebrovascular disease.
The target vessel irradiation positioner of this utility model design can help medical worker and non-medical staff user more accurate, carry out the location that laser intravascular is treated the light quantum receptive area outward more easily, reach the purpose that makes things convenient for middle-older patient accurately to use, improve curative effect.
Description of drawings
Fig. 1 is the position view of this utility model at the mechanism therapeutic instrument casing back side;
Fig. 2 is the structural representation of an embodiment of the present utility model;
Fig. 3 is the structural representation of another embodiment of the present utility model;
Fig. 4 is radial artery angle measurement result figure.
The specific embodiment
Referring to Fig. 1, the target vessel irradiation positioner 2 of this utility model laser therapeutic apparatus is connected with the casing back side 1 of therapeutic instrument, this junction is positioned at about 2cm place, top of the uppermost laser instrument 9 at the casing back side, and is parallel with one side of casing with the line of nearest laser instrument.Labelling 10 is the security bars that prevent the laser diffusion among the figure.This utility model comprises structures such as a mastoid process 21 and connecting rod, and following two embodiment are arranged:
Embodiment 1: referring to Fig. 2, described connecting rod is a screw rod 5, and screws in the screw of the described casing back side 1 correspondence, screw rod 5 near the location mastoid process 21 part be polished rod, be provided with graduated scale 4 on the surface, be provided with anti-skidding stricture of vagina 3 at the side face of mastoid process along length direction.
Embodiment 2: referring to Fig. 3, described connecting rod is by slide bar 6, and this slide bar vertically slides and inserts in the slide opening of the described casing back side 1 correspondence, is provided with in the inner of slide bar 6 and whenever pushes the mechanism 8 of once alternately stretching out with indentation.At the groove 7 that the outer end of the slide opening at the described casing back side 1 is provided with and described location mastoid process is coincide; On described slide bar 6, be provided with scale 4.The mechanism 8 of stretching out with indentation is conventional structure, as the refill expansion mechanism of expansion ball pen.
The parameter of the design of this utility model radial artery target vessel localizer is according to coming from " compatriots' radial artery moves towards measurement report ", and the statistical procedures effluent south information computing center of the college of traditional Chinese medicine of measurement data provides.
The measuring method and the result (referring to Fig. 4) of radial artery trend:
This group measuring object is totally 342 examples, and measuring method is according to the body surface symbol of " practical anatomical atlas upper limb fascicle " described radial artery, with reference to " the somatometry handbook is measured.
1. be m by 2.5cm place, upper limb elbow band mid point below (being designated as the G point) to the vertical length of rasceta midpoint (being designated as the H point).
2. the line of radial artery along upper limb elbow band mid point below 2.5cm to processus styloideus radii extends downwards and rasceta crossing (being designated as the F point), and the vertical length that F point and H are ordered is n.
3. the angle of the line of the trend of radial artery and elbow band mid point and rasceta mid point is radial artery angle α.
Data statistics is handled and is adopted SPSS 10.0 for Windows statistical softwares to carry out statistical analysis sample average (Mean), standard deviation (Std.Deviation), median (Median), minima (Minimum), maximum (Maximum).
The radial artery angle α that counts according to measurement result between 5～15 degree, sample average (Mean)=9.06 degree, median (Median)=9 degree, minima (Minimum)=5 degree, maximum (Maximum)=15 degree (referring to table 1, table 2 and Fig. 4).
SPSS10.0 statistical result (Statistics module) table 1
The radial artery angle
| N Valid Mean Std.Error of Mean Median Std.Deviation Skewness Std.Error of Skewness Kurtosis Std.Error of Kurtosis Range Minimum Maximum | 342 9.06 .13 9.00 2.37 .411 .132 -.262 .263 10 5 15 |
Table 2 zones of different, different sexes and age radial artery angle measurement result
| Classification | The example number | Min | Max | x±SD | Med | Range | CI99％ | |
| The zone | The southerner northerner | 166 176 | 6 5 | 15 15 | 9.05±1.99 9.07±2.23 | 9.00 9.00 | 10.00 10.00 | 8.10～9.99 8.72～9.41 |
| Sex | The men and women | 150 192 | 6 5 | 15 15 | 9.40±2.28 8.80±1.95 | 10.00 9.00 | 9.00 10.00 | 8.93～9.87 8.34～9.26 |
| Age | Young person in middle and old age | 186 156 | 5 6 | 15 15 | 8.58±2.01 9.63±2.05 | 8.50 10.00 | 10.00 10.00 | 8.16～9.01 9.13～10.14 |
| Totally | 342 | 5 | 15 | 9.06±2.37 | 9.00 | 10.00 | 8.10～10.14 | |
This utility model is according to the move towards location of human anatomy principle to the irradiation tremulous pulse, as radial artery and body surface projection is the line of 2.5cm place, elbow band mid point fossa cubitalis below to wrist processus styloideus radii, anchor point of this machine and laser instrument are fixed angle (α=9 degree by the radial artery trend on this basis, median Median) arranges, when anchor point is aimed at the processus styloideus radii place, laser is thrown the irradiation speckle and then is covered on the radial artery fully, what effectively solve that prior art exists can't accurately locate arteries and make the problem of effective underexposure, has improved curative effect greatly.
The cardiovascular and cerebrovascular vessel laser therapeutic apparatus of the band target vessel irradiation positioner that use this utility model is made is as follows through the clinical report that two tame provincial, and municipal level hospitals (the 5th Affiliated Hospital of Zhongshan Medical Univ., Henan College Of Traditional Chinese Medicine second Affiliated Hospital) carry out clinical observation:
1 clinical data
1.1 case is included standard and exclusion standard in
1.1.1 case is included standard in
1) hemorheology detects: any one unusual person and 2 in reflection such as whole blood viscosity, plasma viscosity, packed cell volume, erythrocyte aggregation index, Fibrinogen, the erythrocyte sedimentation rate blood hyperviscosity index), 4) two arbitrary unusual persons.
2) lipids detection: any one unusual person in the index of reflection such as T-CHOL (TC), triglyceride (TG), low density lipoprotein, LDL (LDL-C), high density lipoprotein (HDL-C) hyperlipidemia.
3) nail fold microcirculation detects: pipe loop form (comprising definition, pipe loop number, input branch, output branch, pipe loop length), blood fluidised form (comprising flow velocity, erythrocyte aggregation), pipe loop ambient state (comprise ooze out, venous plexus under hemorrhage, the nipple), any one unusual person and 2 in the index of reflection nail fold microcirculation), 4) two each unusual persons.
4) any one unusual person in fasting glucose, the glycolated hemoglobin.
5) state of an illness allow to be observed person more than three months between 20-70 the age.
6) treatment in accordance with regulations can be judged curative effect person.
Possess in above (1), (2), (3), (4) any one and possess (5), (6) person all can be used as and includes object in.
1.1.2 case exclusion standard:
1) the artificial cardiac pacemaker person is installed.
2) implant electronics heart pump or electric physiology support person.
3) person that has the metal implant in the body.
1.1.3 diagnostic criteria
With reference to Ministry of Public Health " new Chinese medicine clinical research guideline ", " ischemic heart desease name and diagnostic criteria ", " clinical disease diagnosis is according to curing the improvement standard ", " diagnostic criteria of CAIM (Chinese Association Of Integrative Medicine) peripheral vascular disease ", " all kinds of cerebrovascular disease diagnosis main points ", " international hypertension alliance (WHO-ISH) Evaluation of Diagnostic Criteria of Hypertension " and " ADA (ADA) diabetes diagnosis new standard ".
1.2 case physical data
1.2.1 the cardiovascular diseases organizes this group and includes cardiovascular patient totally 37 examples that meet the clinical diagnosis standard, male 20 examples, women 17 examples in; Age: 35～72 years old, 52.45 years old mean age.Coronary heart disease 12 examples wherein, myocardial ischemia 8 examples, angina pectoris 7 examples, rheumatic heart disease 5 examples, pulmonary heart disease 5 examples.
1.2.2 this group of cerebrovascular group is included patients with cerebrovascular disease totally 33 examples that meet the clinical diagnosis standard, male 15 examples, women 18 examples in; Age: 44～76 years old, 56.21 years old mean age.Cerebral infarction 7 examples wherein, cerebral thrombosis 6 examples, cerebral arteriosclerosis 4 examples, carotid artery stenosis 5 examples, vascular dementia 3 examples, vertebra base tremulous pulse blood supply insufficiency 6 examples, migraine 2 examples, this group patient's characteristics all have the performance of blood fat, high blood viscosity and cerebral blood supply insufficiency.
1.2.3 this group of peripheral angiopathy group is included peripheral vessels patient totally 15 examples that meet the clinical diagnosis standard, male 10 examples, women 5 examples in; Age: 31～75 years old, 51.75 years old mean age.Varicose veins of the lower extremity 6 examples wherein, thromboangiitis obliterans 5 examples, atherosclerotic occlusive disease 4 examples, deep venous thrombosis shape 2 examples.1.2.4 this group of metabolic syndrome group is included metabolic syndrome patient's totally 35 examples that meet the clinical diagnosis standard in, male's 19 examples, women's 16 examples, minimum 21 years old of age of onset, maximum 66 years old.Diabetes 12 examples wherein, hyperlipidemia 8 examples, hypertension 15 examples.
2 therapeutic schemes
2.1 own control design: adopt the method for designing of self treating cross-reference to carry out clinical observation, the baseline value of treatment Pretesting cardiovascular and cerebrovascular disease, peripheral angiopathy and metabolic syndrome patient's nail fold microcirculation, blood fat, the every index of hemorheology, metabolic syndrome patient increases the baseline value of surveying blood glucose, glycolated hemoglobin index.Check nail fold microcirculation, blood fat, hemorheology, blood glucose, glycolated hemoglobin after treating 3 courses of treatment, the comparison before and after carrying out self treating with baseline value before the treatment.
2.2 Therapeutic Method
During treatment the target vessel localizer at " the cardiovascular and cerebrovascular vessel laser therapeutic apparatus of the band target vessel irradiation positioner that this utility model is made " back is aimed at wrist processus styloideus radii recess, fixing band is fixed on the left finesse, optical maser wavelength 650nm, laser irradiation power is 20mW, the blood vessel irradiation time is each 40 minutes, once a day, treating a week is a course of treatment, finish the back and had a rest 2 days a course of treatment, repeat the next course of treatment again, treat the improvement situation of each clinical indexes of measurement after two courses of treatment.
Whole cases medicines of any blood fat reducing and blood viscosity lowering of during treating, stopping using.
2.3 observation index
2.3.1 nail fold microcirculation inspection: adopt WX-10 type multi-section position micro-circulation scanning tunnelling microscope (the prosperous smooth optical instrument company limited in Xuzhou), to the form integrated value, the fluidised form integrated value is managed 19 weighted product point-score evaluations that indexs adopt PLA General Hospital Tian Niu to teach such as all State integral values.
2.3.2 hemorheology detects patient and takes a blood sample on an empty stomach, anticoagulant heparin adopts vertebral plate method (SABA-PM4000-3 automatic clinical chemistry analyzer, diligent generation Supreme Being company in Beijing) to carry out the detection of hemorheological indexes.
2.3.3 lipids detection patient takes a blood sample on an empty stomach, the zymetology method is measured T-CHOL (TC), triglyceride (TG), low density lipoprotein, LDL (LDL-C), high density lipoprotein (HDL-C) adopt RG-R801A automatic clinical chemistry analyzer (in Beijing diligent generation Supreme Being company) to detect.
2.3.4 glycolated hemoglobin: blood drawing on an empty stomach, the instant separation of serum of blood specimen, enzymic measuring reagent is provided by Beijing the last nine company.Only require metabolic syndrome group patient test.
2.3.5 blood glucose: blood drawing on an empty stomach, separation of serum, the oxidation enzymatic assays, reagent uses Shanghai Long March test kit.Only require metabolic syndrome group patient test.
The baseline value of all case treatment Pretesting nail fold microcirculation, blood fat, the every index of hemorheology, metabolic syndrome patient increases the baseline value of surveying blood glucose, glycolated hemoglobin index.Check nail fold microcirculation, blood fat, hemorheology, blood glucose, glycolated hemoglobin after treating 3 courses of treatment, carry out comparison before and after self treatment with baseline value before the treatment, to judge the clinical efficacy of " the cardiovascular and cerebrovascular vessel laser therapeutic apparatus of band target vessel irradiation positioner " that this utility model is made.
2.4 statistical method
The statistical procedures effluent south information computing center of the college of traditional Chinese medicine of clinical data provides, and data statistics is handled and adopted SPSS 10.0 for Windows statistical softwares.
Enumeration data is calculated total effective rate, and significance test adopts x
2Check is analyzed; Measurement data is calculated mean, standard deviation, and the t check is analyzed between significance test employing paired t-test or group.
2.5 criterion of therapeutical effect: " practical clinical microcirculation is learned " that " new Chinese medicine clinical research guideline ", PLA General Hospital professor Tian Niu who formulates with reference to Ministry of Health of the People's Republic of China edits, " the disease of tcm diagnosis criterion of therapeutical effect " of State Administration of Traditional Chinese Medicine's issue.
Produce effects: (1) clinical symptoms takes a turn for the better, and improves before the treatment to reach 2/3.(2) hemorheology: indexs such as whole blood viscosity, plasma viscosity, packed cell volume, erythrocyte aggregation index, Fibrinogen improve 〉=55% before the treatment.(3) nail fold microcirculation: the integrated value and the total mark value of pipe loop form, blood fluidised form, all forms of loop improve 〉=60% before the treatment.(4) lipids detection reaches following each person: total gallbladder alcohol (TC) descends 〉=20%, and triglyceride (TG) descends 〉=40%, high density lipoprotein (HDL-C) rising 〉=0.26mmol/L, and low density lipoprotein, LDL (LDL-C) descends 〉=20%.(5) blood glucose: fasting glucose descends 〉=30% before the treatment, or glycolated hemoglobin descends 〉=25% before the treatment.
Effectively: (1) clinical symptoms is partly improved, and alleviates before the treatment to reach 1/3.(2) hemorheology: indexs such as whole blood viscosity, plasma viscosity, packed cell volume, erythrocyte aggregation index, Fibrinogen improve before the treatment 〉=20% but＜55%.(3) nail fold microcirculation: pipe loop form, blood fluidised form, loop week form integrated value and the total mark value improve before the treatment 〉=20% but＜60%.(4) lipids detection reaches following each person: total gallbladder alcohol (TC) descend 〉=10% or＜20%, triglyceride (TG) descend 〉=20% or＜40%, high density lipoprotein (HDL-C) rising 〉=0.104mmol/L but＜0.26mmol/L, low density lipoprotein, LDL (LDL-C) descend 〉=10% or＜20%.(5) blood glucose: fasting glucose descend before the treatment 〉=10% but＜30%, or glycolated hemoglobin descend before the treatment 〉=5% but＜25%.
Invalid: after treating 3 courses of treatment continuously, subjective symptoms and blood fat do not have improvement, and hemorheology and nail fold microcirculation improve all less than 20% before the treatment, and fasting glucose descends＜10% before the treatment, and glycolated hemoglobin descends＜5% before the treatment.
3 therapeutic outcomes:
Table 3 the present invention treats the back clinical efficacy relatively
| The sick kind | Example number (n) | Produce effects n (%) | Effective n (%) | Invalid n (%) | Total effective rate n (%) |
| The cardiovascular diseases organizes cerebrovascular group peripheral angiopathy group metabolic syndrome group and amounts to | 37 33 15 35 120 | 22(59.46％) 18(54.55％) 8(53.33％) 19(54.29％) 67(55.83％) | 13(35.13％) 12(36.36％) 5(33.33％) 13(37.14％) 43(35.83％) | 2(5.41％) 3(9.09％) 2(13.33％) 3(8.57％) 10(8.33％) | 35(94.59％) 30(90.91％) 13(86.67％) 32(91.43％) 110(91.67％) |
The hemorheology measured value compared (x ± s n=95) before and after table 4 the present invention treated
| Inspection item | Unit | Before the treatment | After the treatment | T value | The P value |
| Whole blood contrast viscosity is low to be cut the whole blood contrast viscosity height and cuts plasma viscosity packed cell volume erythrocyte aggregation index Fibrinogen | MPa/s mPa/s mPa/s L/L - g/L | 19.24±0.59 5.30±0.88 1.75±0.47 0.49±1.21 6.43±0.77 4.07±0.91 | 17.11±0.68 4.31±0.74 1.68±0.55 0.42±1.17 4.69±0.62 3.88±0.74 | 6.18 2.41 2.94 3.73 5.46 3.55 | ＜0.01 ＜0.05 ＜0.05 ＜0.01 ＜0.01 ＜0.05 |
Blood fat compared (x ± s n=86) before and after table 5 the present invention treated
| Project | Unit | Before the treatment | After the treatment | The t value | The P value |
| T-CHOL (TC) triglyceride (TG) low-density lipoprotein (LDL-C) high-density lipoprotein (HDL-C) | mmol/L mmol/L mmol/L mmol/L | 8.08±1.23 2.21±0.44 4.25±0.38 1.42±0.20 | 5.42±1.14 1.66±0.62 3.36±0.27 1.74±0.31 | 3.65 2.24 2.86 1.53 | ＜0.01 ＜0.05 ＜0.01 ＜0.05 |
Blood glucose and glycolated hemoglobin compared (x ± s n=15) before and after table 6 the present invention treated
| Project | Unit | Before the treatment | After the treatment | The t value | The P value |
| Blood glucose (TC) glycolated hemoglobin (GSP) | mmol/L mmol/L | 7.72±1.55 2.93±1.04 | 6.13±1.42 2.36±0.95 | 4.17 2.86 | ＜0.05 ＜0.05 |
(x ± s n=120) compared in nail fold microcirculation before and after table 7 the present invention treated
| Integrated value | Before the treatment | After the treatment | ||
| A course of treatment | Two courses of treatment | Three courses of treatment | ||
| Pipe loop form blood fluidised form loop week form total mark value | 1.78±0.35 2.62±0.42 1.47±0.29 5.87±0.53 | 1.55±0.28 * 1.43±0.36 * 1.44±0.18 4.42±0.44 * | 1.24±0.21 ** 1.06±0.29 ** 1.27±0.21 * 3.57±0.64 ** | 1.12±0.19 ** 0.69±0.23 ** 1.01±0.17 * 2.82±0.64 ** |
Annotate: own control is relatively before and after the treatment:
*P＜0.05,
*P＜0.01.
Table 8 the present invention treats the improvement situation of back clinical symptoms
| Symptom | Routine number takes place | Incidence rate | Improve routine number | The improvement rate |
| The dizzy palpitaition pectoralgia lassitude and weak soreness and weakness of waist and knees extremity numbness failure of memory slow in reacting of breathing hard uncomfortable in chest | 98 62 85 41 80 31 25 16 42 | 81.66％ 51.66％ 70.83％ 34.17％ 66.67％ 25.83％ 20.83％ 13.33％ 35.00％ | 94 55 77 33 76 26 18 10 35 | 95.92％ 88.71％ 90.59％ 80.49％ 95.00％ 83.87％ 72.00％ 62.50％ 83.33％ |
The clinical curative effect analysis of the cardiovascular and cerebrovascular vessel laser therapeutic apparatus of the band target vessel irradiation positioner that this utility model is made:
Clinical observation coronary heart disease, angina pectoris, myocardial infarction, rheumatic heart disease, pulmonary heart disease, cerebral infarction, cerebral thrombosis, cerebral arteriosclerosis, varicose veins of the lower extremity, thromboangiitis obliterans, diabetes, hyperlipidemia, the high blood viscosity that diseases such as hypertension cause, hyperlipemia, the cardiovascular and cerebrovascular vessel blood supply insufficiency, microcirculation disturbance and metabolic function syndrome patient be totally 120 examples, learn by statistics and handle, 120 routine patients adopt " the cardiovascular and cerebrovascular vessel laser therapeutic apparatus of the band target vessel irradiation positioner that this utility model is made " treatment, treatment back obvious effective rate 55.83%, effective percentage 35.83%, inefficiency 8.33%, clinical total effective rate is 91.67%, wherein the clinical total effective rate of cardiovascular disease group is 94.59%, the clinical total effective rate of cerebrovascular disease group is 90.91%, the clinical total effective rate of peripheral vascular disease group is 86.67%, and the clinical total effective rate of metabolic syndrome disease group is 91.43%.
The above results shows, the cardiovascular and cerebrovascular vessel laser therapeutic apparatus of the band target vessel irradiation positioner that this utility model is made is to cardiovascular and cerebrovascular disease, the dizziness that peripheral vascular disease and metabolic syndrome patient cause, cardiopalmus, sensation of oppression over the chest with shortness of breath, chest pain, tired unable, numb limbs and tense tendons, bradykinesia, clinical symptoms such as hypomnesis all have significant improvement, clinical symptoms improvement rate to dizziness is 95.92%, the improvement rate of sensation of oppression over the chest with shortness of breath is 90.59%, the improvement rate of chest pain is 80.49%, tired unable improvement rate is 95.00%, the improvement rate of cardiopalmus is 88.71%, the improvement rate of soreness of the waist and knees is 83.87%, unresponsive improvement rate is 72.00%, the improvement rate of hypomnesis is 83.33%, and the improvement rate of numb limbs and tense tendons is 62.50%.
Claims (4)
1. the target vessel of a laser therapeutic apparatus shines positioner, it is characterized in that: comprise location mastoid process and connecting rod, the location mastoid process is connected the outer end of connecting rod, the other end of connecting rod is connected with the casing back side of therapeutic instrument, this junction is positioned at about 2cm place, top of the uppermost laser instrument at the casing back side, and is parallel with one side of casing with the line of nearest laser instrument.
2. the target vessel of laser therapeutic apparatus according to claim 1 shines positioner, it is characterized in that: described connecting rod is a screw rod, and screw in the screw of described casing correspondence, the part near the location mastoid process at screw rod is a polished rod, be provided with graduated scale on the surface, be provided with anti-skidding stricture of vagina at the side face of mastoid process along length direction.
3. the target vessel of laser therapeutic apparatus according to claim 1 shines positioner, it is characterized in that: described connecting rod is a slide bar, this slide bar vertically slides and inserts in the slide opening of described casing back side correspondence, is provided with in the inner of slide bar and whenever pushes the mechanism of once alternately stretching out with indentation.
4. the target vessel of laser therapeutic apparatus according to claim 3 irradiation positioner is characterized in that: at the groove that the outer end is provided with and described location mastoid process is coincide of the slide opening of described casing; On described slide bar, be provided with scale.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200520145013 CN2870896Y (en) | 2005-12-16 | 2005-12-16 | Target blood-vessel radiant positioner of laser therapeutic instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200520145013 CN2870896Y (en) | 2005-12-16 | 2005-12-16 | Target blood-vessel radiant positioner of laser therapeutic instrument |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN2870896Y true CN2870896Y (en) | 2007-02-21 |
Family
ID=37739246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200520145013 Expired - Fee Related CN2870896Y (en) | 2005-12-16 | 2005-12-16 | Target blood-vessel radiant positioner of laser therapeutic instrument |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN2870896Y (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105797280A (en) * | 2016-03-08 | 2016-07-27 | 首都医科大学附属北京朝阳医院 | Deep venous embolism prevention and treatment apparatus |
-
2005
- 2005-12-16 CN CN 200520145013 patent/CN2870896Y/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105797280A (en) * | 2016-03-08 | 2016-07-27 | 首都医科大学附属北京朝阳医院 | Deep venous embolism prevention and treatment apparatus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ahmadi et al. | The efficacy of wet-cupping in the treatment of tension and migraine headache | |
| Shiver et al. | A prospective comparison of ultrasound‐guided and blindly placed radial arterial catheters | |
| Dadaeen et al. | The effect of duration of subcutaneous injection on the extent of bruising and pain intensity at injection sites among patients receiving enoxaparin sodium: a randomized self-controlled clinical trial | |
| CN2870896Y (en) | Target blood-vessel radiant positioner of laser therapeutic instrument | |
| CN100377752C (en) | Multifunction intelligent digital laser therapeutic instrument having blood ressel location and protection device | |
| Kim et al. | The effects of individual education on self-care knowledge and performance for breast cancer patients receiving chemotherapy | |
| Afkar et al. | Predictive factors of ICU bedsores using Braden scale | |
| CN203169199U (en) | Nuclear medicine tumor therapy device | |
| Jie et al. | The pharmaceutical care of a multidrug-resistant bacterial infection patient with tigecycline-induced hypofibri-nogenemia | |
| Du et al. | [Retracted] Application of Data Mining in the Effect of Traditional Chinese Medicine on the Rehabilitation of Cerebral Spasticity of Lower Extremity Exercise Energy | |
| Holden | Dangers of aspirin before cardiac surgery. | |
| Sung et al. | Study of compliance to antihypertensive medication in Korean hypertensive patients using medication event monitoring system | |
| Connors Jr | The transformation of medicine: the role of outcomes research | |
| NEAGOE | THE IMPORTANCE OF BRAIN IMAGING IN A CASE OF ERRONEOUS CLINICAL DIAGNOSIS | |
| Choi et al. | A Comparison of Interventions Recorded in Nursing Notes between Actue and Subacute Stage after a Cerebrovascular Accident | |
| Mofrad et al. | Comparison of the effect of direct venipuncture and venous catheter blood sampling methods on the biochemical results of patients hospitalized in CCU | |
| Katz et al. | Non-adherence, non-compliance or non-concordance in asthma: patients not following the medical regimen | |
| Matthews et al. | Impact of EHR Functionality on Patterns of Depression Treatment in Primary Care | |
| Pettillo et al. | 391 First CARMAT implantation in Italy: a nurse’s experience | |
| Gholami et al. | Is Radial Pulse Assessment for 30 Seconds more Accurate than Electrocardiogram? | |
| Juraeva et al. | REHABILITATION THERAPY FOR PATIENTS WITH TYPE II DIABETES WITH POLYNEUROPATHY AFTER COVID-19 | |
| Yazdankhahfard et al. | Comparsion of biochemical laboratory values obtained by means of routine method of venipuncture versus peripheral intravenous infusion line after administration of fluids | |
| Tan et al. | EE418 Burden of Illness Analysis of Fracture Female Patients with Postmenopausal Osteoporosis in China: A Retrospective Electronic Medical Record Database Analysis | |
| Kang et al. | A case's root cause analysis of osteofascial compartment syndrome induced by radial artery puncture and its defensive strategy | |
| Niu | Analysis of The Impact of Interventional Nursing on The Therapeutic Effect, Negative Emotions, and Quality of Life of Patients Undergoing Cardiovascular and Cerebrovascular Interventional Therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Zhengzhou Bangtai Biotechnology Co. Ltd. Assignor: Lin Ping Contract fulfillment period: 2008.10.26 to 2014.10.25 Contract record no.: 2009410000001 Denomination of utility model: Target blood-vessel radiant positioner of laser therapeutic instrument Granted publication date: 20070221 License type: Exclusive license Record date: 20090106 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.10.26 TO 2014.10.25; CHANGE OF CONTRACT Name of requester: ZHENG ZHOU BANGTAI BIOTECHNOLOGY CO., LTD. Effective date: 20090106 |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070221 Termination date: 20131216 |